Editorial commentary on the special issue of cancer research.
作者信息
Board Editorial
出版信息
J Biomed Res. 2024 Jul 25;38(4):287-288. doi: 10.7555/JBR.38.20240800.
Abstract
摘要
相似文献
1
Editorial commentary on the special issue of cancer research.关于癌症研究特刊的社论评论。
J Biomed Res. 2024 Jul 25;38(4):287-288. doi: 10.7555/JBR.38.20240800.
2
Editorial commentary on the special issue of CRISPR Trends in Biomedical Research.关于《CRISPR生物医学研究趋势》特刊的编辑评论
J Biomed Res. 2021 Mar 25;35(2):75.
3
Editorial commentary on special issue of COVID-19 pandemic.关于新冠疫情特刊的编辑评论
J Biomed Res. 2020 Oct 30;34(6):395-396. doi: 10.7555/JBR.34.20200701.
4
Theory and Theorizing in Nursing Science: Commentary from the Nursing Research Special Issue Editorial Team.护理科学中的理论与理论构建：来自护理研究特刊编辑团队的评论
Nurs Res. 2018 Mar/Apr;67(2):188-195. doi: 10.1097/NNR.0000000000000273.
5
Editorial commentary on special issue of Advances in EEG Signal Processing and Machine Learning for Epileptic Seizure Detection and Prediction.《脑电图信号处理与机器学习在癫痫发作检测与预测方面的进展》特刊的编辑评论
J Biomed Res. 2020 May 28;34(3):149-150. doi: 10.7555/JBR.34.20200700.
6
Editorial commentary on the special issue of Advances in Nanomedicine.关于《纳米医学进展》特刊的编辑评论
J Biomed Res. 2021 May 17;35(4):253-254. doi: 10.7555/JBR.35.20210701.
7
Editorial commentary on the special issue of cardiovascular diseases.关于心血管疾病特刊的编辑评论
J Biomed Res. 2023 Jul 25;37(4):229. doi: 10.7555/JBR.37.20230800.
8
Editorial commentary on the special issue of glia and neurological diseases.关于神经胶质细胞与神经系统疾病特刊的编辑评论
J Biomed Res. 2022 Sep 28;36(5):297-298. doi: 10.7555/JBR.36.20220800.
9
Revisiting the 1990 special issue on minority children: an editorial perspective 15 years later.重温1990年关于少数族裔儿童的特刊：15年后的编辑视角
Child Dev. 2006 Sep-Oct;77(5):1149-54. doi: 10.1111/j.1467-8624.2006.00925.x.
10
Editorial Commentary for the Special Issue "Infectious Disease Prevention and Public Health Promotion".“传染病预防与公共卫生促进”特刊的编辑评论
Healthcare (Basel). 2023 May 14;11(10):1422. doi: 10.3390/healthcare11101422.
本文引用的文献
1
Timosaponin AⅢ induces drug-metabolizing enzymes by activating constitutive androstane receptor (CAR) dephosphorylation of the EGFR signaling pathway.知母皂苷AⅢ通过激活组成型雄烷受体（CAR）使表皮生长因子受体（EGFR）信号通路去磷酸化来诱导药物代谢酶。
J Biomed Res. 2024 May 31;38(4):382-396. doi: 10.7555/JBR.38.20240055.
2
p53 exerts anticancer effects by regulating enhancer formation and activity.p53通过调节增强子的形成和活性发挥抗癌作用。
J Biomed Res. 2024 May 29;38(4):334-347. doi: 10.7555/JBR.37.20230206.
3
Phase separation and transcriptional regulation in cancer development.癌症发展中的相分离与转录调控。
J Biomed Res. 2024 Jan 4:1-15. doi: 10.7555/JBR.38.20230214.
4
Genetic variation of enhances prostate cancer risk through regulating HNRNPA1-related RNA splicing.通过调节与HNRNPA1相关的RNA剪接，[基因名称]的遗传变异增加前列腺癌风险。 （注：原文中“Genetic variation of ”后面缺少具体基因名称，这里补充了[基因名称]以便使译文更完整通顺）
J Biomed Res. 2024 May 29;38(4):358-368. doi: 10.7555/JBR.38.20240030.
5
Potential clinical application of microRNAs in bladder cancer.微小RNA在膀胱癌中的潜在临床应用
J Biomed Res. 2024 May 29;38(4):289-306. doi: 10.7555/JBR.37.20230245.
6
Genetic variants in are associated with gastric cancer risk by influencing immune infiltration.[此处原文不完整，缺少具体基因相关内容]中的基因变异通过影响免疫浸润与胃癌风险相关。
J Biomed Res. 2024 May 29;38(4):348-357. doi: 10.7555/JBR.37.20230161.
7
Cyclopeptide moroidin inhibits vasculogenic mimicry formed by glioblastoma cells regulating β-catenin activation and EMT pathways.环肽moroidin通过调节β-连环蛋白激活和EMT途径抑制胶质母细胞瘤细胞形成的血管生成拟态。
J Biomed Res. 2024 May 29;38(4):322-333. doi: 10.7555/JBR.38.20240015.
8
Identification of cell surface markers for acute myeloid leukemia prognosis based on multi-model analysis.基于多模型分析的急性髓系白血病预后细胞表面标志物的鉴定
J Biomed Res. 2024 May 29;38(4):397-412. doi: 10.7555/JBR.38.20240065.
9
enhances shikonin-induced immunogenic cell death-an efficient tumor vaccine strategy.增强紫草素诱导的免疫原性细胞死亡——一种有效的肿瘤疫苗策略。
J Biomed Res. 2024 May 29;38(4):369-381. doi: 10.7555/JBR.38.20240049.
Zotero 插件